Dynavax Technologies
DVAX
#5495
Rank
S$1.65 B
Marketcap
S$14.12
Share price
-0.64%
Change (1 day)
-17.79%
Change (1 year)

Dynavax Technologies (DVAX) - Cash on Hand

Cash on Hand as of September 2025 : S$0.83 Billion

According to Dynavax Technologies 's latest financial reports the company has S$0.83 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Dynavax Technologies - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.97 B-1.03%
2023-12-31S$0.98 B17.12%
2022-12-31S$0.83 B13.41%
2021-12-31S$0.73 B238.05%
2020-12-31S$0.21 B7.21%
2019-12-31S$0.20 B2.43%
2018-12-31S$0.19 B-22.52%
2017-12-31S$0.25 B117.77%
2016-12-31S$0.11 B-57.53%
2015-12-31S$0.27 B71.18%
2014-12-31S$0.16 B-32.45%
2013-12-31S$0.23 B56.8%
2012-12-31S$0.15 B3.68%
2011-12-31S$0.14 B58.79%
2010-12-31S$92.94 M80.29%
2009-12-31S$51.55 M-47.36%
2008-12-31S$97.92 M-22.88%
2007-12-31S$0.12 B13.71%
2006-12-31S$0.11 B-10.7%
2005-12-31S$0.12 B16.42%
2004-12-31S$0.10 B117.29%
2003-12-31S$49.43 M-3.13%
2002-12-31S$51.03 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Agenus
AGEN
S$4.48 M-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$5.13 B 511.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$23.61 B 2,711.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$9.52 B 1,034.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$10.60 B 1,163.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
S$5.76 B 586.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
S$19.42 B 2,213.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.85 B 240.07%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
S$12.24 B 1,357.98%๐Ÿ‡บ๐Ÿ‡ธ USA